We are live on
!
Find out more
TCM
Traynor Capital Management Portfolio holdings
AUM
$2.18B
1-Year Est. Return
62.36%
This Fund
S&P 500
This Quarter
Est. Return
+13.85%
1 Year Est. Return
+62.36%
3 Year Est. Return
+225.14%
5 Year Est. Return
+309.6%
10 Year Est. Return
+1,325.9%
AUM
$845M
AUM Growth
+$115M
(+16%)
Cap. Flow
+$33.4M
Cap. Flow
% of AUM
3.95%
Top 10 Holdings %
Top 10 Hldgs %
52.31%
Holding
236
New
36
Increased
90
Reduced
74
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$7.92M |
| 2 |
Vale
VALE
|
+$4M |
| 3 |
Amazon
AMZN
|
+$3.69M |
| 4 |
Apple
AAPL
|
+$3.46M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$3.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$6.43M |
| 2 |
CRISPR Therapeutics
CRSP
|
+$2.93M |
| 3 |
iShares S&P 500 Value ETF
IVE
|
+$2.49M |
| 4 |
Boeing
BA
|
+$1.72M |
| 5 |
QuidelOrtho
QDEL
|
+$1.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.29% |
| 2 | Consumer Discretionary | 14.66% |
| 3 | Communication Services | 13.06% |
| 4 | Healthcare | 6.45% |
| 5 | Financials | 4.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
AbbVie
ABBV
$435B
| $528K | 0.06% |
3,900
-360
| -8% | -$42.5K |
|
127
PepsiCo
PEP
$190B
| $528K | 0.06% |
3,042
-12
| -0.4% | -$1.96K |
|
128
Salesforce
CRM
$158B
| $488K | 0.06% |
1,922
+325
| +20% | +$91.3K |
|
129
ProShares Ultra NASDAQ Biotechnology
BIB
$86.2M
| $476K | 0.06% |
5,877
+858
| +17% | +$73.5K |
|
130
FuboTV Inc
FUBO
$273M
| $467K | 0.06% |
+2,512
| New | +$706K |
|
|
KNDI
131
Kandi Technologies Group
KNDI
$65.5M
| $465K | 0.06% |
+145,050
| New | +$592K |
|
|
SCHW
132
Charles Schwab
SCHW
$187B
| $454K | 0.05% |
5,409
+2
| +0% | +$162 |
|
133
Bread Financial
BFH
$4.38B
| $436K | 0.05% |
6,551
-1,908
| -23% | -$141K |
|
134
Vanguard Information Technology ETF
VGT
$149B
| $433K | 0.05% |
7,560
+48
| +0.6% | +$2.63K |
|
135
Everest Group
EG
$14.4B
| $431K | 0.05% |
1,576
| – | – |
|
136
iShares Core International Aggregate Bond Fund
IAGG
$11.4B
| $408K | 0.05% |
7,485
+17
| +0.2% | +$936 |
|
|
EOS
137
Eaton Vance Enhance Equity Income Fund II
EOS
$1.18B
| $389K | 0.05% |
15,820
-2,000
| -11% | -$48.1K |
|
138
CVS Health
CVS
$122B
| $373K | 0.04% |
3,623
-2,034
| -36% | -$188K |
|
|
BFIN
139
DELISTED
BankFinancial
BFIN
| $360K | 0.04% |
33,824
| – | – |
|
140
Camden Property Trust
CPT
$11.3B
| $357K | 0.04% |
2,000
| – | – |
|
141
Cisco
CSCO
$479B
| $348K | 0.04% |
5,500
+962
| +21% | +$55K |
|
142
iShares MSCI EAFE ETF
EFA
$80.2B
| $347K | 0.04% |
4,419
+193
| +5% | +$15.3K |
|
143
Direxion Daily S&P 500 High Beta Bull 3X ETF
HIBL
$88.1M
| $346K | 0.04% |
4,650
| – | – |
|
144
Eli Lilly
LLY
$1.06T
| $345K | 0.04% |
1,250
+50
| +4% | +$12.7K |
|
145
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$147M
| $343K | 0.04% |
+1,159
| New | +$412K |
|
146
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.74B
| $337K | 0.04% |
3,819
+499
| +15% | +$43.4K |
|
147
Kroger
KR
$34.8B
| $331K | 0.04% |
7,318
+652
| +10% | +$27.4K |
|
148
Abbott
ABT
$187B
| $305K | 0.04% |
2,172
+364
| +20% | +$46.6K |
|
149
CME Group
CME
$94.8B
| $303K | 0.04% |
1,328
-80
| -6% | -$17.6K |
|
150
Sherwin-Williams
SHW
$89.8B
| $297K | 0.04% |
+845
| New | +$273K |
|
Similar funds
SIG
ICM
CAG
ET
MIAS
ORCP
TAL
GC
Traynor Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Traynor Capital Management held 236 positions worth $845M, up 16% from $730M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Traynor Capital Management deployed $33.4M of net new capital in Q4 2021, opening 36 new positions and adding to 90 existing holdings. Its largest new stake was Vale: 301,199 shares worth $4.22M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was iShares S&P 500 Value ETF, an estimated $2.49M trimmed.
- Traynor Capital Management's largest Q4 2021 buy was Vale: 301,199 shares worth $4.22M.
- Traynor Capital Management added most to Advanced Micro Devices in Q4 2021, an estimated $7.92M increase.
- Traynor Capital Management's biggest Q4 2021 reduction was iShares S&P 500 Value ETF, cutting an estimated $2.49M.
- Traynor Capital Management fully exited Biogen in Q4 2021, selling an estimated $6.43M.
- Traynor Capital Management's ten largest holdings make up 52% of its $845M portfolio in Q4 2021.
- Traynor Capital Management opened 36 new positions and closed 13 in Q4 2021.
- Traynor Capital Management's portfolio value rose 16% quarter-over-quarter to $845M.
Based on Traynor Capital Management's 13F filing for Q4 2021, filed 1 Feb 2022.